Testing effectiveness (Phase 2)Active Not RecruitingNCT03536767
What this trial is testing
Open-Label Study of AG10 in Patients with Cardiomyopathy
Who this might be right for
Amyloid Cardiomyopathy
Eidos Therapeutics, a BridgeBio company 55
Showing 20 of 0 results